Overuse of acid suppressant drugs in patients with chronic renal failure

Nephrology Dialysis Transplantation

Volumn 18, Issue 3, 2003, Pages 570-575

  Strid, Hans ^a   Simrén, Magnus ^a   Björnsson, Einar S ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acid suppressive therapy; Chronic renal failure; H2 receptor antagonists; Oesophagogastroduodenoscopy; Proton pump inhibitors

Indexed keywords

ANTACID AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DRUG ABUSE; DRUG INDICATION; ENDOSCOPY; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PEPTIC ULCER; PRIORITY JOURNAL; RHEUMATIC DISEASE;

AGED; AGED, 80 AND OVER; ANTACIDS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG DISEASES; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROTON PUMPS; RENAL DIALYSIS; RHEUMATIC DISEASES; TIME FACTORS;

EID: 0037340077     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/18.3.570     Document Type: Article

References (21)

1. Valori RM, Brown CM, Strangeways P, Bradburn M. Reducing community dyspepsia drug costs: a controlled trial. Gut 2001; 49: 495-501
2. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-3122
3. Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long term acid suppressing treatment in general practice. Br Med J 1994; 308: 827-830
4. Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant 2002; 17: 1434-1439
5. Ekstrom P, Carling L, Wetterhus S et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-758
6. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24: 2-17
7. Ala-Kaila K. Upper gastrointestinal findings in chronic renal failure. Scand J Gastroenterol 1987; 22: 372-376
8. Hurenkamp GJ, Grundmeijer HG, Van Der Ende A, Tytgat GN, Assendelft WJ, Van Der Hulst RW. Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study. Aliment Pharmacol Ther 2001; 15: 1047-1054
9. Talley NJ, Meineche-Schmidt V, Pare P et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-1065
10. Hallas J, Bytzer P. Screening for drug related dyspepsia: an analysis of prescription symmetry. Eur J Gastroenterol Hepatol 1998; 10: 27-32
11. Van Vlem B, Schoonjans R, Vanholder R. Dyspepsia and gastric emptying in chronic renal failure patients. Clin Nephrol 2001; 56: 302-307
12. Messer J, Reitman D, Sacks HS, Smith H, Jr, Chalmers TC. Association of adrenocorticosteroid therapy and peptic-ulcer disease. N Engl J Med 1983; 309: 21-24
13. Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med 1994; 236: 619-632
14. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal antiinflammatory drugs. Ann Intern Med 1991; 114: 735-740
15. Gillen D, McColl KE. Problems related to acid rebound and tachyphylaxis. Best Pract Res Clin Gastroenterol 2001; 15: 487-495
16. Smith AD, Gillen D, Cochran KM, El-Omar E, McColl KE. Dyspepsia on withdrawal of ranitidine in previously asymptomatic volunteers. Am J Gastroenterol 1999; 94: 1209-1213
17. Korman MG, Laver MC, Hansky J. Hypergastrinaemia in chronic renal failure. Br Med J 1972; 1: 209-210
18. Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux disease management. Gut 1999; 44
19. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-595
20. Inadomi JM, Jamal R, Murata GH et al. Step-down management of gastroesophageal reflux disease. Gastroenterology 2001; 121: 1095-1100
21. Kliem V, Bahlmann J, Hartmann M, Huber R, Luhmann R, Wurst W. Pharmacokinetics of pantoprazole in patients with end-stage renal failure. Nephrol Dial Transplant 1998; 13: 1189-1193